Living with ovarian cancer as a chronic disease — and celebrating milestones
Joan Janssen, an ovarian cancer patient at Dana-Farber, speaks about the development of targeted therapies and how she is using them to… View more
TINA’S WISH GRANTS FOCUS ON EARLY DETECTION OF OVARIAN CANCER
Only 20 percent of women with ovarian cancer are diagnosed at an early stage when more successful treatment options are available, according… View more
TINA’S WISH RAISES $1.6M FOR OVARIAN CANCER RESEARCH AND CELEBRATES ITS 10TH ANNIVERSARY AT THE AMERICAN MUSEUM OF NATURAL HISTORY
NEW YORK, Sept. 29, 2017 /PRNewswire/ — More than 700 Tina’s Wish supporters came together during Ovarian Cancer Awareness Month to raise… View more
LEVINE WEIGHS IN ON PRECISION MEDICINE RAPIDLY BEING INCORPORATED INTO OVARIAN CANCER CARE
Douglas Levine, MD, director of the Division of Gynecologic Oncology at Perlmutter Cancer Center, NYU Langone School of Medicine, sat down with… View more
TINA’S WISH RESEARCH CONSORTIUM FUELS COLLABORATION ACROSS FOUR LEADING INSTITUTIONS WITH $900,000 GRANT
Tina’s Wish, the only nonprofit organization dedicated exclusively to funding scientific research for the early detection and prevention of ovarian cancer, is… View more
LEVINE WEIGHS IN ON PARP INHIBITOR ADVANCES IN OVARIAN CANCER
Douglas Levine, MD, director of the Division of Gynecologic Oncology at Perlmutter Cancer Center, NYU Langone School of Medicine, sat down with… View more